Immune Response to Anti-HER2 Therapies in Patients With HER2-Positive Stage I-IV Breast Cancer
Status: RECRUITING
Study type: OBSERVATIONAL
Conditions: Breast Adenocarcinoma|HER2-Positive Breast Carcinoma
Interventions: PROCEDURE: Biospecimen Collection
Sponsor: Mayo Clinic